Inventor
Sze-Wan Li
Inventor
Toronto, CA
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes21%
C07BGeneral methods of organic chemistry3%
C30BSingle-crystal growth3%
B05DProcesses for applying fluent materials to surfaces, in general1%
B32BLayered products, i.e. products built-up of strata of flat or non-flat, e.g. cellular or honeycomb, form1%
C01GCompounds containing metals not covered by subclasses c01d or c01f1%
C01PIndexing scheme relating to structural and physical aspects of solid inorganic compounds1%
C07KPeptides1%
PatentTitleYear
11,067,063Embedded conductive wires in polymer artificial muscle actuating devices202111,046,589Multi-element perovskite material as well as preparation and luminescent application thereof202110,968,325Preparation of large ultrathin free-standing polymer films202110,875,863RIPK2 inhibitors and method of treating cancer with same202010,584,130Solid forms of TTK inhibitor202010,570,143Pyrazolopyrimidine compounds202010,501,474HPK1 inhibitors and methods of using same2019RE047731Kinase inhibitors and method of treating cancer with same201910,358,436Kinase inhibitors and method of treating cancer201910,239,881RIPK2 inhibitors and method of treating cancer with same201910,167,289Pyrazolopyrimidine compounds201910,106,545Pyrazolopyrimidine compounds201810,077,255Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones20189,907,800'Kinase inhibitors and method of treating cancer'20189,796,703'Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones'20179,657,025'Pyrazolopyrimidine compounds'20179,579,327'Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones'20179,580,390'Indazole compounds as kinase inhibitors and method of treating cancer with same'20179,573,954'Pyrazolopyrimidine compounds'20179,139,563'Kinase inhibitors and method of treating cancer'20158,999,968'Kinase inhibitors and method of treating cancer with same'20158,980,934'Kinase inhibitors and method of treating cancer with same'20158,921,545'Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones'20148,765,748'Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer'20148,481,533'Kinase inhibitors and method of treating cancer'20138,481,525'Kinase inhibitors and method of treating cancer with same'20138,263,596'Kinase inhibitors and method of treating cancer'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2020Patents assigned to UNIV HEALTH NETWORK (24)· patent assignee history
2012–2015Patents assigned to LI SZE-WAN (6)· patent assignee history
2012–2015Patents assigned to PAULS HEINZ W (6)· patent assignee history
2012–2014Patents assigned to FORREST BRYAN T (5)· patent assignee history
2012–2014Patents assigned to LIU YONG (5)· patent assignee history
2012–2020Based in Toronto, CA· patent location history
2021Based in Richardson, TX, US· patent location history
2021Based in Hubei, CN· patent location history
2021Based in Fremont, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV HEALTH NETWORK | 24 | 2012–2020 |
| LI SZE-WANself | 6 | 2012–2015 |
| PAULS HEINZ W | 6 | 2012–2015 |
| FORREST BRYAN T | 5 | 2012–2014 |
| LIU YONG | 5 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Toronto, CA | 24 | 2012–2020 |
| Richardson, Texas, US | 1 | 2021 |
| Hubei, CN | 1 | 2021 |
| Fremont, California, US | 1 | 2021 |